<ul><li>Nicolas Simon, co-founder of Wandercraft, aims to advance the field of robotics with AI-powered exoskeletons to help individuals with mobility challenges, including those with Charcot-Marie-Tooth disease.</li><li>Wandercraft's Personal Exoskeleton, currently in clinical trials, integrates AI mechanisms for stability and movement, enabling users to stand, walk, and control the device with a joystick.</li><li>The company's FDA-cleared Atalante X exoskeleton has already helped patients in over 100 clinical settings worldwide, and the latest Personal Exoskeleton is designed for indoor and outdoor use, adapting to users' movements in real time.</li><li>Wandercraft is utilizing NVIDIA technologies for simulation, reinforcement learning, and AI-driven robotics solutions to enhance the functionality of exoskeletons and improve users' mobility in daily life.</li></ul>

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Discover more